Article
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.
Current rheumatology reports - 1 Apr 2014
Akter Tanjina, Silver Richard M, Bogatkevich Galina S
Abstract excerpt
Systemic sclerosis (scleroderma, SSc) is a heterogeneous autoimmune connective tissue disease of unknown etiology. Interstitial lung disease (ILD) is a frequent complication, and a significant contributor to morbidity and mortality among SSc patients. SSc-ILD most commonly occurs within 10 years of diagnosis, and may be seen in patients with either the limited or diffuse cutaneous subset of SSc. SSc-ILD is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.